Refresh

Dr. Reddy's Laboratories Ltd.

Price on BSE   03 Sep,15:50 LIVE
1,155.00
-6.00
(-0.52%)

© 2026 Rediff.com
  • Volume :
  • 27,997.00
  • Prev Close :
  • 1,161.00
  • Day's H/L (Rs.) :
  • 1,164.30 - 1,155.00
  • 52wk H/L (Rs.) :
  • 1,414.40 - 1,080.05
  • Mkt Cap (Rs. Cr) :
  • 96,407.86
Price on NSE   03 Sep,15:59 LIVE
1,155.00
-1.50
(-0.13%)

© 2026 Rediff.com
  • Volume :
  • 338,269.00
  • Prev Close :
  • 1,156.50
  • Day's H/L (Rs.) :
  • 1,164.30 - 1,155.00
  • 52wk H/L (Rs.) :
  • 1,414.90 - 1,101.00
  • Mkt Cap (Rs. Cr) :
  • 0.00

View more

Market News

AI Effect: 'Nearly 3 Million Jobs Are At Risk In India'
Rediff.com   6 day(s) ago
Dr Reddy's Labs plunges 69% to Rs 443 crore, hit by lenalidomide exit and semaglutide issues
Rediff.com   23 Jul 2026
Indian drugmakers in no rush to shift to US despite tariff threat
Rediff.com   10 Aug 2026
Q1 Earnings, West Asia Tensions, Crude Oil to Drive Market Movement This Week
Rediff.com   19 Jul 2026
Indian Pharma Bets Beyond US Generics
Rediff.com   26 Jun 2026
Report Card - Dr. Reddy's Laboratories Ltd.
PE Ratios
30.11
EPS (Rs.)
38.56
Sales (Rs. Cr)
5,136.60
Face Value (Rs.)
1
Net Profit Margin(%)
15.68
Last Bonus
1:1
Last Dividend(%)
800
Return on Average Equity
10.26

News for Dr. Reddy's Laboratories Ltd.

Dr Reddy''s Launches Generic Sugammadex Injection in US
Dr Reddy''s launches generic Sugammadex injection in the US, offering an affordable alternative to Bridion for reversing muscle relaxants during surgery.
Aug 04, 2026 13:33
Dr Reddy''s shares tumble 9% post-Q1 earnings, hit 52-week low
Dr Reddy''s shares plunged nearly 9% to a 52-week low after Q1 net profit fell 69.2%. Semaglutide API issues and generics revenue dip cited.
Jul 23, 2026 11:00
Dr Reddy''s CEO: US Tariffs Will Hike Drug Prices
Dr Reddy''s CEO Erez Israeli warns US tariffs on generic medicines will lead to higher drug prices. India, a major exporter, will be impacted by Trump''s plan.
Jul 22, 2026 19:03
Dr Reddy''s Q1 Profit Plunges 69.2% Amid Semaglutide Issue
Dr Reddy''s Q1 net profit fell 69.2% to Rs 434.8 cr, impacted by semaglutide ingredient provisions & North America generics dip. Revenue also declined.
Jul 22, 2026 17:19
US Tariffs on Generic Drugs: India''s Pharma Exports at Risk
GTRI warns US tariffs on generic medicines could significantly impact India''s largest pharma export market. Trump''s plan aims to reshore production, affecting Indian companies.
Jul 22, 2026 14:24

More News for Dr. Reddy's Laboratories Ltd. »

About Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology. Wikipedia

News for Pharmaceuticals

Goyal: India's Sensitivities Uncompromised in US Trade Pact
Commerce Minister Piyush Goyal assures that no Indian sensitivities were compromised in the US trade agreement, despite details not being public. Consultations held.
Sep 03, 2026 21:56
Ashok Leyland MD Shenu Agarwal Elected SIAM President
Ashok Leyland MD & CEO Shenu Agarwal elected SIAM President for 2026-27. K N Radhakrishnan is VP, Santosh Iyer is Treasurer.
Sep 03, 2026 21:51
Sebi to Review Derivative Settlement Price After CAS Rollout
Sebi plans to review the methodology for derivative contract settlement prices at expiry, following concerns after the Closing Auction Session (CAS) rollout.
Sep 03, 2026 21:46
Banking System Liquidity Hits Record High on FCNR(B) Flows
India's banking system liquidity surplus reached a record Rs 9.71 lakh crore, driven by FCNR(B) inflows. RBI may use VRRR auctions or ICRR to manage.
Sep 03, 2026 21:46
Piyush Goyal: Automakers Must Increase India Localization
Commerce Minister Piyush Goyal warns "black sheep" automakers to increase localization in India, citing data analysis. He praises Maruti Suzuki for leading exports.
Sep 03, 2026 21:45

More News »

Top News

Tea Board, ISRO, NIT Partner for AI Tea Monitoring System
Tea Board, ISRO, and NIT Rourkela launch 'CHAAYANKAN,' an AI-based system using satellite & UAV data for tea plantation monitoring, pest management, and yield estimation.
Sep 03, 2026 22:05
Bluehill.VC Funds Makr Microsystems: Rs 10.2 Cr for Chip Tech
Bluehill.VC leads Rs 10.2 crore funding for semiconductor metrology startup Makr Microsystems, boosting chip tech development and commercialization.
Sep 03, 2026 22:04
Goyal: India's Sensitivities Uncompromised in US Trade Pact
Commerce Minister Piyush Goyal assures that no Indian sensitivities were compromised in the US trade agreement, despite details not being public. Consultations held.
Sep 03, 2026 21:56
Sriram Viji Appointed ACMA President; Anjali Singh President-Designate
ACMA announces Sriram Viji as President and Anjali Singh as President-Designate. New leadership to drive innovation, sustainability, and global competitiveness for India's auto component industry.
Sep 03, 2026 21:53
Ashok Leyland MD Shenu Agarwal Elected SIAM President
Ashok Leyland MD & CEO Shenu Agarwal elected SIAM President for 2026-27. K N Radhakrishnan is VP, Santosh Iyer is Treasurer.
Sep 03, 2026 21:51

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com